Mental health and menopause — friends or foes? The review of methods of treating mental disorders and menopause co-occurrence
, 2
Streszczenie
Introduction and objective: Menopause is not only about changes related to the reproductive system but also several other symptoms, including those associated with mental health. Mental disorders may affect up to half of women, including anxiety disorders, sleep disorders, and depression. This study aims to indicate diagnostic and therapeutic methods in patients with the above-mentioned disorders. The available literature from 2000–2024 in the PubMed database was explored. Brief description of the state of knowledge: The problem of mental disorders co-occurring with menopause is often ignored and not considered in the differential diagnosis. A lot of responsibility in diagnosing the first symptoms of menopause lies with primary care physicians, who are often not properly prepared for this. Due to the limited time of a doctor’s visit, introducing more widely available information programs may be helpful. If symptoms of menopause and mental health disorders coexist, the use of hormone replacement therapy (HRT) should be considered. During the diagnostic process, there should be considered the role of stress, which is a factor in the development and exacerbatio n of symptoms. It’s wor th suggesting appropriate ways of dealing with it, not necessarily only through pharmacotherapy. Conclusions: The effectiveness of diagnosing mental disorders co-occurring with menopause in the future will depend on the education of both, hea lthcare workers and pa - tients. More educated patients will help detect disturbing symptoms in the early stage and be more willing to cooperate.
Słowa kluczowe: menopauseanxietydepressionsleep disordersmental disorders
Referencje
- Pengo MF, Won CH, Bourjeily G. Sleep in Women Across the Life Span. Chest. 2018; 154(1): 196–206.
- Kedare JS, Kadiani A, Patkar P, et al. Mental health and well-being of women (menarche, perinatal, and menopause). Indian J Psychiatry. 2024; 66(Suppl 2): S320–S330.
- Stute P, Lozza-Fiacco S. Strategies to cope with stress and anxiety during the menopausal transition. Maturitas. 2022; 166: 1–13.
- Leonhardt M. Low mood and depressive symptoms during perimenopause - Should General Practitioners prescribe hormone replacement therapy or antidepressants as the first-line treatment? Post Reprod Health. 2019; 25(3): 124–130.
- Anderson D, Yoshizawa T, Gollschewski S, et al. Relationship between menopausal symptoms and menopausal status in Australian and Japanese women: preliminary analysis. Nurs Health Sci. 2004; 6(3): 173–180.
- Tandon VR, Sharma S, Mahajan A, et al. Menopause and Sleep Disorders. J Midlife Health. 2022; 13(1): 26–33.
- Bandelow B, Werner AM, Kopp I, et al. The German Guidelines for the treatment of anxiety disorders: first revision. Eur Arch Psychiatry Clin Neurosci. 2022; 272(4): 571–582.
- Feng P, Lin L, Wang Y, et al. Impacts of menopause hormone therapy on mood disorders among postmenopausal women. Climacteric. 2022; 25(6): 579–585.
- Soares CN. Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window. Med Clin North Am. 2019; 103(4): 651–667.
- Kandola A, Ashdown-Franks G, Hendrikse J, et al. Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. Neurosci Biobehav Rev. 2019; 107: 525–539.
- Lum KJ, Simpson EE. The impact of physical activity on psychological well-being in women aged 45-55 years during the Covid pandemic: A mixed-methods investigation. Maturitas. 2021; 153: 19–25.
- Caretto M, Giannini A, Simoncini T. An integrated approach to diagnosing and managing sleep disorders in menopausal women. Maturitas. 2019; 128: 1–3.
- Gambacciani M, Ciaponi M, Cappagli B, et al. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas. 2005; 50(2): 91–97.
- Cintron D, Lipford M, Larrea-Mantilla L, et al. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine. 2017; 55(3): 702–711.
- Meeta M, Digumarti L, Agarwal N, et al. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019-2020. J Midlife Health. 2020; 11(2): 55–95.
- Baranwal N, Yu PK, Siegel NS. Sleep physiology, pathophysiology, and sleep hygiene. Prog Cardiovasc Dis. 2023; 77: 59–69.
- Mead MP, Irish LA. Application of health behaviour theory to sleep health improvement. J Sleep Res. 2020; 29(5): e12950.
- Parry BL. Optimal management of perimenopausal depression. Int J Womens Health. 2010; 2: 143–151.
- Santoro N, Teal S, Gavito C, et al. Use of a levonorgestrel-containing intrauterine system with supplemental estrogen improves symptoms in perimenopausal women: a pilot study. Menopause. 2015; 22(12): 1301–1307.
- Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial. JAMA Psychiatry. 2018; 75(2): 149–157.
